The National Institute for Occupational Safety and Health (NIOSH) has published the 2024 update to its List of Hazardous Drugs in Healthcare Settings, marking the first revision since 2016. The ...
In January 2022, the U.S. Food and Drug Administration (FDA) released finalized guidance on premarket pathways for combination products. While the guidance is not binding, it provides industry ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈